Biopharmaceuticals

How are biopharmaceuticals produced in bioreactors? What makes them different from traditional drugs made via chemical synthesis? What is the full technological route for producing a batch of biopharmaceutical products based on allogeneic MSCs? Biopharmaceuticals are products in which active pharmaceutical ingredients (APIs) are living cells or substances produced by these cells in industrial culture […]

Why use stem cells?

What dormant power lies in stem cells? How to unleash this power?   Thus far, MSCs have remained unavailable for veterinary therapies. By using them as the active pharmaceutical ingredient in the medicinal products we develop, we are pushing the boundaries of treatment for companion animals. MSC are the body’s natural reservoir of new cells used […]

Biopharmaceuticals and xenobiotics

What are the differences between pharmaceuticals produced via chemical synthesis and stem cell-based biopharmaceuticals? Why is the efficacy and safety of novel therapies superior to traditional ones?   Xenobiotics Steroidal anti-inflammatory drugs (SAIDs) and non-steroidal anti-inflammatory drugs (NSAIDs) are xenobiotics – chemical compounds produced via chemical synthesis which do not occur naturally in mammals. Their […]

Stem cell technology development trends

What has science yet to discover about the mechanisms of action of MSCs? Is it possible to replace living stem cells without sacrificing the therapeutic effect? Can they be desiccated rather than frozen? Today, the largest public database of clinical trials includes approximately 500 clinical trials (in various phases) that utilise mesenchymal stem cells from […]

Advantages of AlloMSCs

Our technology for manufacturing MSC-based medicinal products for veterinary use utilises the therapeutic potential of safe allografts (one donor – many recipients). This approach allows the pharmaceutical to be batch-produced, without the need to collect the patient’s biological material each time. This is in contrast to treatments based on autologous transplants, wherein the MSCs are […]